Results 51 to 60 of about 12,689 (175)

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign. [PDF]

open access: yesPLoS ONE, 2017
Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign.
Alpha Oumar Diallo   +14 more
doaj   +1 more source

Spinal Epidural Abscess Complicated by Compressive Myelopathy and Secondary Cord Ischemia: A Case Report

open access: yesCase Reports in Surgery, Volume 2026, Issue 1, 2026.
Spinal cord infarction (SCI) is an uncommon condition with a generally poor prognosis for neurologic recovery. There are numerous possible causes for SCI, yet frequently the etiology is not fully elucidated. Literature regarding SCI is sparse, with no conclusive algorithmic strategies for diagnosis and treatment. This case report describes the hospital
Molly E. Milano   +5 more
wiley   +1 more source

EPIDEMIOLOGICAL CHARACTERIZATION OF REPORTED CASES OF MENINGOCOCCAL DISEASE IN THE CITY OF SÃO PAULO, BRAZIL, BETWEEN 2019 AND 2025

open access: yesBrazilian Journal of Infectious Diseases
Introduction: Meningitis is a communicable infectious disease with a significant disease burden and possible unfavorable outcomes. In this context, the World Health Organization (WHO) and the Pan American Health Organization (PAHO) developed the roadmap “
Nathália Amaro Schmidt   +1 more
doaj   +1 more source

A rare case of peripheral facial paralysis associated with meningococcal meningitis - case report [PDF]

open access: yesRomanian Journal of Pediatrics
Introduction. Meningococcal meningitis is a severe form of bacterial meningitis caused by the bacterium Neisseria meningitidis (N. meningitidis). It is a medical emergency and requires prompt treatment to prevent severe complications or death. Peripheral
Nicoleta-Ana Tomsa   +3 more
doaj   +1 more source

Design of B‐Cell Multi‐Epitope Subunit Vaccines Against Glaesserella parasuis by Reverse Vaccinology: An In Silico and In Vivo Study

open access: yesTransboundary and Emerging Diseases, Volume 2026, Issue 1, 2026.
Glässer’s disease caused by Glaesserella parasuis (GPS) is a severe disease that results in substantial economic losses to the swine industry worldwide. Here we describe a multiepitope vaccine cocktail (MEVC) that was designed using reverse vaccinology and immunoinformatics. The MEVC was comprised of three multiepitope subunits (MESs, designated as TB,
Yan Gong   +10 more
wiley   +1 more source

Systematic Review of Postvaccination Ocular Adverse Events: A Comprehensive Analysis of Published Reports

open access: yesJournal of Medical Virology, Volume 97, Issue 12, December 2025.
ABSTRACT Ocular adverse events following COVID‐19 vaccination are well described; however, systematic analyses of non‐COVID antiviral vaccines remain limited. This review aimed to evaluate ocular complications associated with non‐COVID antiviral immunizations, including influenza, varicella‐zoster (VZV), human papillomavirus (HPV), and hepatitis B (HBV)
Yaru Zou   +5 more
wiley   +1 more source

Impact of serogroup A meningococcal conjugate vaccine for Africa

open access: yesHuman Vaccines & Immunotherapeutics, 2018
The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated ...
James M. Stuart
doaj   +1 more source

Vaccination Uptake and Patient Perceptions Among Haemodialysis Patients: Insights From a Cross‐Sectional Study

open access: yesJournal of Renal Care, Volume 51, Issue 4, December 2025.
ABSTRACT Background Haemodialysis patients face an elevated risk of infectious diseases due to immunosuppression and frequent exposure to healthcare settings. Vaccination is a critical preventive strategy for this population; however, coverage remains inconsistent across different vaccines.
Eirini Potamianou   +6 more
wiley   +1 more source

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA‐TMA)

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 2040-2051, November 2025.
ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler   +6 more
wiley   +1 more source

Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.

open access: yesPLoS ONE, 2018
BackgroundNigeria reports high rates of mortality linked with recurring meningococcal meningitis outbreaks within the African meningitis belt. Few studies have thoroughly described the response to these outbreaks to provide strong and actionable public ...
Assad Hassan   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy